Chronic lymphocytic leukemia (CLL) is a type of blood cancer described as a neoplasm composed of monomorphic small mature B cells that co-express CD5 and CD23 surface marker antigens [1], which leads to a progressive accumulation of monoclonal B lymphocytes [2]. This evidence concerns the gene CD5 and B-cell chronic lymphocytic leukemia.